SC
BIIB icon

Schubert & Co’s Biogen BIIB Stock Holding History

Schubert & Co’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-45
Closed -$12.5K – 211
2023
Q1 		$12.5K Sell
45
-3
-6% -$830 0.01% 186
2022
Q4 		$13.3K Buy
48
+12
+33% +$3.39K 0.01% 172
2022
Q3 		$10K Buy
36
+4
+13% +$850 0.01% 192
2022
Q2 		$7K Buy
32
+16
+100% +$3.27K 0.01% 227
2022
Q1 		$3K Buy
16
+6
+60% +$1.3K ﹤0.01% 245
2021
Q4 		$2K Buy
+10
New +$2.57K ﹤0.01% 313

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Schubert & Co's BIIB Position: Q2 2023 in Review

Schubert & Co sold out of Biogen (BIIB) in Q2 2023, closing a stake of 45 shares — an estimated $12.5K sold.

Schubert & Co first reported a position in BIIB in Q4 2021 and held it in 6 quarters. The position peaked at $13.3K in Q4 2022. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.

  • Schubert & Co reported no remaining Biogen position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 45 Biogen shares in Q2 2023, an estimated $12.5K.
  • Schubert & Co first reported a position in Biogen in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's Biogen position peaked at $13.3K in Q4 2022.
  • 1,008 funds tracked by Wall St. Rank held Biogen as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.